Studies endorsed by the UK's NHS reveal that Anastrozol, over an eleven-year span, can reduce the incidence of breast cancer by approximately half. This potentially translates to preventing around 2000 cases if a quarter of eligible women opt for the treatment, with half of them adhering to the suggested five-year regimen.

From caregiver to patient to coach, Isabel Galiano has journeyed through the world of cancer from multiple angles. Her unique perspective, marked by personal battles and triumphs, allows her to provide invaluable insights into the challenges faced by those diagnosed with breast cancer. In this comprehensive article, we'll delve into Galiano's experiences and the wisdom she's gained from her remarkable journey.